Carnegie Lake Advisors’s Pfizer PFE Stock Holding History

Carnegie Lake Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$982K	Sell	34,425 -15,152	-31%	-$403K	0.36%	68
2026 Q2	$1.19M	Sell	49,577 -1,941	-4%	-$50.8K	0.45%	55
2026 Q1	$1.45M	Sell	51,518 -1,767	-3%	-$47K	0.57%	44
2025 Q4	$1.33M	Sell	53,285 -8,913	-14%	-$225K	0.51%	49
2025 Q3	$1.58M	Buy	62,198 +636	+1%	+$15.7K	0.61%	43
2025 Q2	$1.49M	Sell	61,562 -2,397	-4%	-$55.9K	0.59%	47
2025 Q1	$1.62M	Buy	63,959 +1,595	+3%	+$41.7K	0.66%	42
2024 Q4	$1.66M	Buy	62,364 +800	+1%	+$21.7K	0.67%	43
2024 Q3	$1.78M	Buy	+61,564	New	+$1.8M	0.71%	37

Other funds holding PFE

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Carnegie Lake Advisors's PFE Position: Q3 2026 in Review

Carnegie Lake Advisors reduced its Pfizer (PFE) stake by 31% in Q3 2026, selling an estimated $403K and leaving 34,425 shares worth $982K. The position accounts for 0.36% of the portfolio, ranked #68.

Carnegie Lake Advisors first reported a position in PFE in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.78M in Q3 2024. 2,277 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Carnegie Lake Advisors held 34,425 shares of Pfizer worth $982K as of Q3 2026.
Carnegie Lake Advisors sold 15,152 Pfizer shares in Q3 2026, an estimated $403K.
Pfizer made up 0.36% of Carnegie Lake Advisors's portfolio in Q3 2026, its #68 holding.
Carnegie Lake Advisors first reported a position in Pfizer in Q3 2024 and has held it in 9 quarters since.
Carnegie Lake Advisors's Pfizer position peaked at $1.78M in Q3 2024.
2,277 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Carnegie Lake Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.